Is IVA or JBIO more undervalued in 2026?

CirclFi compares Inventiva S.A. - American Depos (IVA) and Jade Biosciences, Inc. (JBIO) using 13 institutional-grade valuation models. IVA has a Quality of Company score of 4.4/10 while JBIO scores 4.1/10.

Which is a better buy — IVA or JBIO?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do IVA and JBIO valuations compare?

IVA at $4.93 and JBIO at $21.04 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

IVA vs JBIO Valuation Comparison 2026 — Intrinsic Value Analysis

IVA

Pharmaceutical Preparations

Inventiva S.A. - American Depos

Quality

4.4

out of 10

Value Trap

SAFE

Price

$4.93

Last close

Models

7/13

Active

JBIO

Pharmaceutical Preparations

Jade Biosciences, Inc.

Quality

4.1

out of 10

Value Trap

SAFE

Price

$21.04

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	IVA Fair Value	IVA Upside	JBIO Fair Value	JBIO Upside
Bayesian DCF	Intrinsic	$0.58	-88.3%	$6.33	-69.9%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	—	—	$3.86	-81.7%
PWERM	Option-Based	$5.84	+18.4%	$21.39	+1.7%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for IVA vs JBIO — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

IVA vs JBIO — Which Stock Is More Undervalued?

IVA scores higher with a 4.4/10 quality rating vs JBIO's 4.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Inventiva S.A. - American Depos (IVA) and Jade Biosciences, Inc. (JBIO) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

IVA currently trades at $4.93 with a QOC of 4.4/10, while JBIO trades at $21.04 with a QOC of 4.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).